These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8274161)

  • 1. Effect of BOF-4272 on the oxidation of allopurinol and pyrazinamide in vivo. Is xanthine dehydrogenase or aldehyde oxidase more important in oxidizing both allopurinol and pyrazinamide?
    Yamamoto T; Moriwaki Y; Suda M; Nasako Y; Takahashi S; Hiroishi K; Nakano T; Hada T; Higashino K
    Biochem Pharmacol; 1993 Dec; 46(12):2277-84. PubMed ID: 8274161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo study on the conversion of allopurinol and pyrazinamide.
    Nasako Y; Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Hada T; Higashino K
    Adv Exp Med Biol; 1994; 370():43-6. PubMed ID: 7660944
    [No Abstract]   [Full Text] [Related]  

  • 3. In vitro oxidation of pyrazinamide and allopurinol by rat liver aldehyde oxidase.
    Moriwaki Y; Yamamoto T; Nasako Y; Takahashi S; Suda M; Hiroishi K; Hada T; Higashino K
    Biochem Pharmacol; 1993 Sep; 46(6):975-81. PubMed ID: 8216357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolism of pyrazinamide and allopurinol in hereditary xanthine oxidase deficiency.
    Yamamoto T; Higashino K; Kono N; Kawachi M; Nanahoshi M; Takahashi S; Suda M; Hada T
    Clin Chim Acta; 1989 Feb; 180(2):169-75. PubMed ID: 2731378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of xanthinuria: a study on the metabolism of pyrazinamide and allopurinol.
    Yamamoto T; Kario K; Suda M; Moriwaki Y; Takahashi S; Higashino K
    Jpn J Med; 1991; 30(5):430-4. PubMed ID: 1803043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2.
    Nakamura M; Fujita K; Toyoda Y; Takada T; Hasegawa H; Ichida K
    Drug Metab Pharmacokinet; 2018 Feb; 33(1):77-81. PubMed ID: 29342419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zonal distribution of allopurinol-oxidizing enzymes in rat liver.
    Moriwaki Y; Yamamoto T; Yamakita J; Takahashi S; Tsutsumi Z; Higashino K
    Adv Exp Med Biol; 1998; 431():47-50. PubMed ID: 9598029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference of the plasma concentration and urinary excretion of allopurinol, oxypurinol, and purine bases between dietary intake and fasting.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Yamakita J; Higashino K
    Int J Clin Pharmacol Ther; 1996 Apr; 34(4):157-62. PubMed ID: 8861734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hepatic allopurinol oxidizing enzyme in mice].
    Huh K; Iwata H; Yamamoto I
    Nihon Yakurigaku Zasshi; 1975 Mar; 71(2):175-83. PubMed ID: 124299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of a combined deficiency of xanthine oxidase and aldehyde oxidase in xanthinuric patients not forming oxipurinol.
    Reiter S; Simmonds HA; Zöllner N; Braun SL; Knedel M
    Clin Chim Acta; 1990 Mar; 187(3):221-34. PubMed ID: 2323062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamics of oxypurinol after administration of allopurinol to healthy subjects.
    Graham S; Day RO; Wong H; McLachlan AJ; Bergendal L; Miners JO; Birkett DJ
    Br J Clin Pharmacol; 1996 Apr; 41(4):299-304. PubMed ID: 8730975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of classical xanthinuria (type 1) with diabetes mellitus and Hashimoto's thyroiditis.
    Shibutani Y; Ueo T; Yamamoto T; Takahashi S; Moriwaki Y; Higashino K
    Clin Chim Acta; 1999 Jul; 285(1-2):183-9. PubMed ID: 10481935
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel xanthine dehydrogenase inhibitor (BOF-4272).
    Sato S; Tatsumi K; Nishino T
    Adv Exp Med Biol; 1991; 309A():135-8. PubMed ID: 1789192
    [No Abstract]   [Full Text] [Related]  

  • 14. Xylitol-induced increase in the concentration of oxypurines and its mechanism.
    Yamamoto T; Moriwaki Y; Takahashi S; Suda M; Higashino K
    Int J Clin Pharmacol Ther; 1995 Jun; 33(6):360-5. PubMed ID: 7582389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentrations and urinary excretion of purine bases (uric acid, hypoxanthine, and xanthine) and oxypurinol after rigorous exercise.
    Kaya M; Moriwaki Y; Ka T; Inokuchi T; Yamamoto A; Takahashi S; Tsutsumi Z; Tsuzita J; Oku Y; Yamamoto T
    Metabolism; 2006 Jan; 55(1):103-7. PubMed ID: 16324927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Study of the metabolism of pyrazinamide using a high-performance liquid chromatographic analysis of urine samples.
    Yamamoto T; Moriwaki Y; Takahashi S; Hada T; Higashino K
    Anal Biochem; 1987 Feb; 160(2):346-9. PubMed ID: 3578761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response.
    Yun J; Mattsson J; Schnyder K; Fontana S; Largiadèr CR; Pichler WJ; Yerly D
    Clin Exp Allergy; 2013 Nov; 43(11):1246-55. PubMed ID: 24152157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of angiotensin II infusion on renal excretion of purine bases and oxypurinol.
    Moriwaki Y; Yamamoto T; Tsutsumi Z; Takahashi S; Hada T
    Metabolism; 2002 Jul; 51(7):893-5. PubMed ID: 12077737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ethanol as a xanthine dehydrogenase inhibitor.
    Yamamoto T; Moriwaki Y; Takahashi S; Suda M; Higashino K
    Metabolism; 1995 Jun; 44(6):779-85. PubMed ID: 7783663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of allopurinol and of oxypurinol on turkey liver xanthine dehydrogenase.
    Fhaoláin IN; Coughlan MP
    FEBS Lett; 1978 Jun; 90(2):305-8. PubMed ID: 668894
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.